ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
R-HSA-5663202	Diseases of signal transduction	45/125	285/3951	1.99854791961484e-21	1.45494288547961e-18	7.57344474801414e-19	1499/1956/2099/2253/2308/4609/4088/4089/6772/55294/2932/8850/4193/2033/3065/9794/4851/2064/2066/2261/2264/5594/5595/5155/5156/5159/6714/1026/1387/5170/5295/6464/6774/7048/5290/1385/2534/207/4296/5879/5515/5728/4087/2309/1523	45
R-HSA-1257604	PIP3 activates AKT signaling	32/125	191/3951	8.16553718217067e-16	2.27532733453901e-13	1.18438091445061e-13	1956/2099/2253/2308/3725/7157/2932/4193/3065/5468/2064/2066/2261/2264/5594/5595/5155/5156/5159/6714/1026/5170/5295/5290/1385/7189/2534/207/5879/5515/5728/2309	32
R-HSA-2219528	PI3K/AKT Signaling in Cancer	24/125	99/3951	9.37634890606737e-16	2.27532733453901e-13	1.18438091445061e-13	1956/2099/2253/2308/2932/4193/2064/2066/2261/2264/5155/5156/5159/6714/1026/5170/5295/5290/1385/2534/207/5879/5728/2309	24
R-HSA-9006925	Intracellular signaling by second messengers	33/125	230/3951	3.01890189679924e-14	5.49440145217461e-12	2.86001232328349e-12	1956/2099/2253/2308/3725/7157/2932/4193/3065/5468/2064/2066/2261/2264/5594/5595/5155/5156/5159/5580/6714/1026/5170/5295/5290/1385/7189/2534/207/5879/5515/5728/2309	33
R-HSA-8939211	ESR-mediated signaling	25/125	127/3951	4.12494719007113e-14	6.00592310874356e-12	3.12627576510654e-12	1956/2099/2625/3725/4602/4609/8850/2033/3065/2066/5594/5595/6714/1387/5170/5295/6464/5290/1385/6667/2288/207/857/5747/2309	25
R-HSA-9006934	Signaling by Receptor Tyrosine Kinases	41/125	386/3951	4.32398082066052e-13	5.24643006240143e-11	2.73093525515401e-11	1020/1499/1956/2099/2253/6772/2064/2066/2261/2264/5594/1432/5595/4914/5155/5156/5159/5580/6714/1398/5170/5295/6464/6774/51741/2241/5290/1385/2534/5771/6197/207/5058/5062/5879/857/5515/5747/387/10451/4208	41
R-HSA-199418	Negative regulation of the PI3K/AKT network	21/125	106/3951	5.05143202835565e-12	5.25348930948987e-10	2.7346098198617e-10	1956/2099/2253/2064/2066/2261/2264/5594/5595/5155/5156/5159/6714/5295/5290/7189/2534/207/5879/5515/5728	21
R-HSA-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	20/125	99/3951	1.17334964987256e-11	1.06774818138403e-09	5.55797202571211e-10	1956/2099/2253/2064/2066/2261/2264/5594/5595/5155/5156/5159/6714/5295/5290/7189/2534/207/5879/5515	20
R-HSA-9614085	FOXO-mediated transcription	16/125	59/3951	1.33838803082535e-11	1.08260720715651e-09	5.63531802452779e-10	2308/2908/4088/4089/8850/10891/10971/2033/3065/1026/1387/6794/207/857/4087/2309	16
R-HSA-9006931	Signaling by Nuclear Receptors	25/125	164/3951	1.75693640691561e-11	1.27904970423456e-09	6.6578642788381e-10	1956/2099/2625/3725/4602/4609/8850/2033/3065/2066/5594/5595/6714/1387/5170/5295/6464/5290/1385/6667/2288/207/857/5747/2309	25
R-HSA-9616222	Transcriptional regulation of granulopoiesis	12/125	29/3951	1.94936948172791e-11	1.29012816608902e-09	6.71553122891911e-10	1869/4602/4609/2033/1026/6774/1385/1050/1051/2624/2313/7027	12
R-HSA-8878159	Transcriptional regulation by RUNX3	15/125	56/3951	7.44332745098742e-11	4.51561865359904e-09	2.35052445820656e-09	1499/4609/4088/4089/7157/8850/4193/2033/9794/4851/6714/1026/1387/2309/6932	15
R-HSA-5683057	MAPK family signaling cascades	28/125	224/3951	1.20849877395768e-10	6.767593134163e-09	3.5227494625487e-09	1956/2253/2308/3725/4609/983/2064/2066/2261/2264/5594/5595/5155/5156/5159/5979/6714/6464/1843/2534/4296/5058/5062/5879/5515/5747/2309/2118	28
R-HSA-8864260	Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	11/125	28/3951	2.786116574053e-10	1.37755943244437e-08	7.17063903528011e-09	1956/2099/4609/7341/7329/2033/2064/1026/1387/51741/4605	11
R-HSA-8878166	Transcriptional regulation by RUNX2	16/125	71/3951	2.83837795146504e-10	1.37755943244437e-08	7.17063903528011e-09	367/2099/2908/4089/6772/983/55294/2932/10891/25/5594/5595/6714/1026/207/2101	16
R-HSA-166520	Signaling by NTRKs	18/125	96/3951	5.10589130132189e-10	2.32318054210146e-08	1.20929004504992e-08	1020/5594/1432/5595/4914/6714/1398/5295/6464/6774/5290/1385/2534/6197/5879/5515/387/4208	18
R-HSA-1538133	G0 and Early G1	10/125	23/3951	5.66465353163349e-10	2.42580457119364e-08	1.26270914637031e-08	1869/4149/4609/898/983/3065/1874/5933/4605/7027	10
R-HSA-2871796	FCERI mediated MAPK activation	11/125	30/3951	6.71628213425472e-10	2.5733965230197e-08	1.33953549492061e-08	3725/5594/5595/5599/6464/5602/5601/5058/5062/5879/10451	11
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	11/125	30/3951	6.71628213425472e-10	2.5733965230197e-08	1.33953549492061e-08	3725/5594/1432/5595/5599/1385/6197/5602/5601/5515/4208	11
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	17/125	91/3951	1.7177769929013e-09	6.25270825416072e-08	3.25473535497088e-08	3725/5594/5595/5599/5170/5295/6464/5290/5970/7189/2534/5602/5601/5058/5062/5879/10451	17
R-HSA-2559583	Cellular Senescence	18/125	106/3951	2.76555039834705e-09	9.58724138093644e-08	4.99046688423528e-08	1869/3725/7157/898/4193/5594/1432/5595/1026/5599/6774/5970/6667/6197/5602/5601/1051/7027	18
R-HSA-450341	Activation of the AP-1 family of transcription factors	7/125	10/3951	2.97917731852274e-09	9.85836858129344e-08	5.1315972950631e-08	3725/5594/1432/5595/5599/5602/5601	7
R-HSA-449147	Signaling by Interleukins	34/125	369/3951	3.90239083350049e-09	1.23519153338624e-07	6.42956842132804e-08	836/2308/2625/3725/4609/4088/6772/7157/5594/1432/5595/1026/1398/5599/5295/6464/6774/5290/29110/1385/5970/6095/7189/2534/5771/6197/207/5602/5601/5062/5515/2309/3091/4208	34
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	15/125	73/3951	4.22906791937299e-09	1.28281726887647e-07	6.67747566216788e-08	1956/2099/2253/2064/2066/2261/2264/5155/5156/5159/6714/5295/5290/2534/5879	15
R-HSA-4420097	VEGFA-VEGFR2 Pathway	17/125	97/3951	4.81627166569509e-09	1.40249830905041e-07	7.30045389326415e-08	1499/1432/5580/6714/1398/5170/5295/5290/2534/207/5058/5062/5879/857/5747/387/10451	17
R-HSA-187037	Signaling by NTRK1 (TRKA)	15/125	76/3951	7.62382894608157e-09	2.13467210490284e-07	1.11116535246533e-07	5594/1432/5595/4914/6714/1398/5295/6464/6774/5290/1385/6197/5515/387/4208	15
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	16/125	88/3951	8.15921905991678e-09	2.19996721319238e-07	1.14515355226902e-07	3725/5594/1432/5595/5599/9641/29110/148022/1385/5970/7189/6197/5602/5601/5515/4208	16
R-HSA-9009391	Extra-nuclear estrogen signaling	14/125	66/3951	9.32252518815399e-09	2.42385654892004e-07	1.2616951382464e-07	1956/2099/5594/5595/6714/5170/5295/6464/5290/1385/207/857/5747/2309	14
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	19/125	128/3951	9.97258694027340e-09	2.50346320431691e-07	1.30313295771268e-07	367/2099/8856/2908/142/7341/7157/7329/4193/10891/2033/3065/5468/1387/9641/9063/5970/6095/10155	19
R-HSA-2990846	SUMOylation	19/125	130/3951	1.29918870618753e-08	3.08265046690442e-07	1.60461851949912e-07	367/2099/8856/2908/142/7341/7157/7329/4193/10891/2033/3065/5468/1387/9641/9063/5970/6095/10155	19
R-HSA-166166	MyD88-independent TLR4 cascade 	16/125	91/3951	1.3550111942437e-08	3.08265046690442e-07	1.60461851949912e-07	3725/5594/1432/5595/5599/9641/29110/148022/1385/5970/7189/6197/5602/5601/5515/4208	16
R-HSA-937061	TRIF(TICAM1)-mediated TLR4 signaling 	16/125	91/3951	1.3550111942437e-08	3.08265046690442e-07	1.60461851949912e-07	3725/5594/1432/5595/5599/9641/29110/148022/1385/5970/7189/6197/5602/5601/5515/4208	16
R-HSA-2262752	Cellular responses to stress	26/125	241/3951	1.57429885762924e-08	3.47299869198207e-07	1.80780730062688e-07	367/1869/3725/2908/7157/898/2932/4193/2033/5594/1432/5595/1026/1387/5599/6774/5970/6667/5052/2288/6197/5602/5601/1051/3091/7027	26
R-HSA-157118	Signaling by NOTCH	18/125	118/3951	1.6342893531719e-08	3.49930190914454e-07	1.82149896947952e-07	1869/1956/3725/4609/4088/6772/7157/55294/8850/2033/3065/9794/4851/1387/1385/207/3091/7027	18
R-HSA-194138	Signaling by VEGF	17/125	105/3951	1.6887462008031e-08	3.51259209767045e-07	1.82841693921539e-07	1499/1432/5580/6714/1398/5170/5295/5290/2534/207/5058/5062/5879/857/5747/387/10451	17
R-HSA-1362300	Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1	7/125	12/3951	1.86472728470443e-08	3.77089295351341e-07	1.96287082600467e-07	1869/983/3065/1874/5933/4605/7027	7
R-HSA-8953897	Cellular responses to external stimuli	26/125	244/3951	2.04653672654959e-08	4.02669928899487e-07	2.09602623487298e-07	367/1869/3725/2908/7157/898/2932/4193/2033/5594/1432/5595/1026/1387/5599/6774/5970/6667/5052/2288/6197/5602/5601/1051/3091/7027	26
R-HSA-1912408	Pre-NOTCH Transcription and Translation	9/125	25/3951	3.17394840421861e-08	6.08061694281881e-07	3.1651563033759e-07	1869/3725/7157/8850/2033/9794/4851/1387/7027	9
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	9/125	27/3951	6.90118073128768e-08	1.2882204031737e-06	6.70560071056293e-07	4609/4088/4089/3065/6667/1874/5933/4087/7027	9
R-HSA-1227986	Signaling by ERBB2	11/125	45/3951	8.33582531124081e-08	1.51712020664583e-06	7.89709766328077e-07	1956/2064/2066/5580/6714/5295/6464/5290/2534/207/387	11
R-HSA-2559580	Oxidative Stress Induced Senescence	11/125	46/3951	1.06647955497329e-07	1.89365150248915e-06	9.85706392273128e-07	1869/3725/7157/4193/5594/1432/5595/5599/5602/5601/7027	11
R-HSA-400253	Circadian Clock	12/125	57/3951	1.25133117236784e-07	2.16897403210426e-06	1.12902060664768e-06	2908/1453/10891/2033/1387/406/1385/6095/9575/8553/3091/4208	12
R-HSA-186763	Downstream signal transduction	9/125	29/3951	1.39767740391365e-07	2.31525359331886e-06	1.20516381375765e-06	6772/5155/5156/5159/6714/1398/5295/6774/5290	9
R-HSA-1362277	Transcription of E2F targets under negative control by DREAM complex	7/125	15/3951	1.39932909486305e-07	2.31525359331886e-06	1.20516381375765e-06	1869/4149/4609/3065/1874/5933/7027	7
R-HSA-4090294	SUMOylation of intracellular receptors	9/125	30/3951	1.94386332070562e-07	3.14473888327487e-06	1.63693753322579e-06	367/2099/8856/2908/7341/7329/5468/9063/6095	9
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	10/125	39/3951	2.04742327183765e-07	3.2402698736909e-06	1.68666448023239e-06	4609/142/4088/4089/3065/6667/1874/5933/4087/7027	10
R-HSA-8848021	Signaling by PTK6	11/125	49/3951	2.14853021069897e-07	3.25860415289343e-06	1.69620806107813e-06	1956/2908/898/2064/2066/1398/6774/207/5879/387/3091	11
R-HSA-9006927	Signaling by Non-Receptor Tyrosine Kinases	11/125	49/3951	2.14853021069897e-07	3.25860415289343e-06	1.69620806107813e-06	1956/2908/898/2064/2066/1398/6774/207/5879/387/3091	11
R-HSA-450294	MAP kinase activation	12/125	60/3951	2.28373866305516e-07	3.37830834241647e-06	1.75851793416705e-06	3725/5594/1432/5595/5599/1385/7189/6197/5602/5601/5515/4208	12
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	14/125	84/3951	2.35777870898834e-07	3.37830834241647e-06	1.75851793416705e-06	3725/5594/1432/5595/5599/148022/1385/5970/7189/6197/5602/5601/5515/4208	14
R-HSA-453279	Mitotic G1-G1/S phases	15/125	97/3951	2.36667205306648e-07	3.37830834241647e-06	1.75851793416705e-06	1869/4149/4609/898/983/3065/25/6714/1026/207/1874/5515/5933/4605/7027	15
R-HSA-9617828	FOXO-mediated transcription of cell cycle genes	7/125	16/3951	2.42268046973214e-07	3.39175265762499e-06	1.7655161317886e-06	2308/4088/4089/1026/857/4087/2309	7
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	13/125	72/3951	2.47660156555744e-07	3.40182252778456e-06	1.77075782244425e-06	25/5594/5595/5580/6714/1398/5295/5290/2534/5058/5879/5747/10451	13
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	14/125	85/3951	2.74789028655201e-07	3.63720750656339e-06	1.89328325963392e-06	3725/5594/1432/5595/5599/148022/1385/5970/7189/6197/5602/5601/5515/4208	14
R-HSA-975155	MyD88 dependent cascade initiated on endosome	14/125	85/3951	2.74789028655201e-07	3.63720750656339e-06	1.89328325963392e-06	3725/5594/1432/5595/5599/148022/1385/5970/7189/6197/5602/5601/5515/4208	14
R-HSA-9607240	FLT3 Signaling	22/125	208/3951	3.43307271648615e-07	4.46299453143199e-06	2.32313191341168e-06	1956/2253/2064/2066/2261/2264/5594/5595/5155/5156/5159/5979/6714/5170/5295/6464/5290/1843/2534/4296/5515/5747	22
R-HSA-389356	CD28 co-stimulation	9/125	32/3951	3.61196175682525e-07	4.61317220871715e-06	2.40130421506388e-06	6714/5170/5295/5290/2534/207/5058/5062/5879	9
R-HSA-9615017	FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes	8/125	24/3951	3.85843688380379e-07	4.84300353691234e-06	2.52093879885547e-06	2308/2908/4088/4089/10891/3065/4087/2309	8
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	16/125	115/3951	4.10347881863761e-07	5.0632755592681e-06	2.6355974571089e-06	3725/5594/1432/5595/5599/9641/29110/148022/1385/5970/7189/6197/5602/5601/5515/4208	16
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	14/125	89/3951	4.95763972957988e-07	6.01526953855692e-06	3.13114088183992e-06	3725/5594/1432/5595/5599/148022/1385/5970/7189/6197/5602/5601/5515/4208	14
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	8/125	25/3951	5.52480961010113e-07	6.59354327238299e-06	3.43215092258224e-06	2308/2932/4193/1026/5170/1385/207/2309	8
R-HSA-9018519	Estrogen-dependent gene expression	12/125	65/3951	5.74570983096014e-07	6.74657541441772e-06	3.51180906476341e-06	2099/2625/3725/4602/4609/8850/2033/3065/2066/1387/6667/2288	12
R-HSA-1912422	Pre-NOTCH Expression and Processing	9/125	34/3951	6.40183723613268e-07	7.39767858397554e-06	3.85072916459109e-06	1869/3725/7157/8850/2033/9794/4851/1387/7027	9
R-HSA-170834	Signaling by TGF-beta Receptor Complex	12/125	66/3951	6.83603184069822e-07	7.77598621879422e-06	4.04765043199237e-06	4609/142/4088/4089/3065/7048/6667/1874/5933/4087/387/7027	12
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	13/125	79/3951	7.63613859334534e-07	8.29717745664986e-06	4.31894720126367e-06	3725/5594/1432/5595/5599/1385/5970/7189/6197/5602/5601/5515/4208	13
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	13/125	79/3951	7.63613859334534e-07	8.29717745664986e-06	4.31894720126367e-06	3725/5594/1432/5595/5599/1385/5970/7189/6197/5602/5601/5515/4208	13
R-HSA-975871	MyD88 cascade initiated on plasma membrane	13/125	79/3951	7.63613859334534e-07	8.29717745664986e-06	4.31894720126367e-06	3725/5594/1432/5595/5599/1385/5970/7189/6197/5602/5601/5515/4208	13
R-HSA-448424	Interleukin-17 signaling	12/125	68/3951	9.58200342760956e-07	1.02583801401467e-05	5.33981615160904e-06	3725/5594/1432/5595/5599/1385/7189/6197/5602/5601/5515/4208	12
R-HSA-6791312	TP53 Regulates Transcription of Cell Cycle Genes	9/125	36/3951	1.08908481000165e-06	1.14906339374087e-05	5.98124380778936e-06	1869/7157/898/983/2033/1026/1874/5933/7027	9
R-HSA-5688426	Deubiquitination	17/125	139/3951	1.13889257980186e-06	1.18444828299394e-05	6.16543351471686e-06	367/2099/2625/4609/4088/4089/7157/983/8850/4193/2033/7048/7189/5728/4087/387/3091	17
R-HSA-3700989	Transcriptional Regulation by TP53	23/125	242/3951	1.23971836352037e-06	1.27114784315891e-05	6.61673255548307e-06	1020/1869/3725/7157/898/983/4193/10971/2033/3065/1432/1026/1387/5170/5052/6794/207/1874/5515/5728/5933/6872/7027	23
R-HSA-5654741	Signaling by FGFR3	9/125	37/3951	1.40109850569967e-06	1.41666626687411e-05	7.37420266157722e-06	2253/2261/5594/5595/6714/5295/6464/5290/5515	9
R-HSA-5654743	Signaling by FGFR4	9/125	38/3951	1.78738677769992e-06	1.78248982762403e-05	9.27843172273932e-06	2253/2264/5594/5595/6714/5295/6464/5290/5515	9
R-HSA-5218920	VEGFR2 mediated vascular permeability	8/125	29/3951	1.97065762556926e-06	1.93560264672792e-05	1.0075433094593e-05	1499/5170/207/5058/5062/5879/857/10451	8
R-HSA-597592	Post-translational protein modification	35/125	496/3951	1.99409613330486e-06	1.93560264672792e-05	1.0075433094593e-05	367/2099/2625/4609/8856/2908/142/4088/4089/7341/7157/7329/983/1453/55294/8850/4193/10891/10987/2033/3065/5468/1387/7048/9641/9063/5970/6095/7189/5728/4087/10155/7704/387/3091	35
R-HSA-5684996	MAPK1/MAPK3 signaling	20/125	196/3951	2.24191219927451e-06	2.1387884703354e-05	1.11330805280617e-05	1956/2253/983/2064/2066/2261/2264/5594/5595/5155/5156/5159/5979/6714/6464/1843/2534/4296/5515/5747	20
R-HSA-5687128	MAPK6/MAPK4 signaling	9/125	39/3951	2.26218011285475e-06	2.1387884703354e-05	1.11330805280617e-05	2308/3725/4609/983/5058/5062/5879/2309/2118	9
R-HSA-109606	Intrinsic Pathway for Apoptosis	10/125	50/3951	2.46156487160466e-06	2.29746054683102e-05	1.1959019619132e-05	836/1869/7157/10971/5594/5595/5599/6774/207/7027	10
R-HSA-186712	Regulation of beta-cell development	8/125	30/3951	2.61657445956878e-06	2.41122304628616e-05	1.25511899459661e-05	2308/8850/2033/9794/4851/1387/207/3172	8
R-HSA-166058	MyD88:MAL(TIRAP) cascade initiated on plasma membrane	13/125	88/3951	2.7265672446281e-06	2.45054438776451e-05	1.27558701503069e-05	3725/5594/1432/5595/5599/1385/5970/7189/6197/5602/5601/5515/4208	13
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	13/125	88/3951	2.7265672446281e-06	2.45054438776451e-05	1.27558701503069e-05	3725/5594/1432/5595/5599/1385/5970/7189/6197/5602/5601/5515/4208	13
R-HSA-168898	Toll-like Receptor Cascades	16/125	134/3951	3.34796426602741e-06	2.97233900691214e-05	1.54719786363269e-05	3725/5594/1432/5595/5599/9641/29110/148022/1385/5970/7189/6197/5602/5601/5515/4208	16
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	13/125	90/3951	3.53641378964796e-06	3.03602611518484e-05	1.58034904781166e-05	3725/5594/1432/5595/5599/1385/5970/7189/6197/5602/5601/5515/4208	13
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	13/125	90/3951	3.53641378964796e-06	3.03602611518484e-05	1.58034904781166e-05	3725/5594/1432/5595/5599/1385/5970/7189/6197/5602/5601/5515/4208	13
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	9/125	41/3951	3.54481071141087e-06	3.03602611518484e-05	1.58034904781166e-05	4609/55294/8850/2033/3065/9794/4851/1387/3091	9
R-HSA-69205	G1/S-Specific Transcription	7/125	23/3951	4.31399965006421e-06	3.65185086656598e-05	1.9009055985595e-05	1869/898/983/3065/1874/5933/7027	7
R-HSA-69206	G1/S Transition	12/125	79/3951	5.01114775235272e-06	4.19323628012963e-05	2.18271408450935e-05	1869/4149/4609/898/983/3065/1026/207/1874/5515/5933/7027	12
R-HSA-109581	Apoptosis	15/125	123/3951	5.33683428939949e-06	4.41501745759413e-05	2.29815830643997e-05	836/1499/1869/7157/10971/5594/5595/5580/5599/6774/148022/207/5062/5747/7027	15
R-HSA-5673001	RAF/MAP kinase cascade	19/125	190/3951	5.61755240432585e-06	4.59503162960586e-05	2.3918614613333e-05	1956/2253/2064/2066/2261/2264/5594/5595/5155/5156/5159/5979/6714/6464/1843/2534/4296/5515/5747	19
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	7/125	24/3951	5.931475634287e-06	4.6936024584358e-05	2.44317074181158e-05	5594/1432/5595/1385/6197/5515/4208	7
R-HSA-2559585	Oncogene Induced Senescence	7/125	24/3951	5.931475634287e-06	4.6936024584358e-05	2.44317074181158e-05	1869/7157/4193/5594/5595/6667/7027	7
R-HSA-9634638	Estrogen-dependent nuclear events downstream of ESR-membrane signaling	7/125	24/3951	5.931475634287e-06	4.6936024584358e-05	2.44317074181158e-05	1956/5594/5595/1385/207/5747/2309	7
R-HSA-9617629	Regulation of FOXO transcriptional activity by acetylation	5/125	10/3951	6.4963290845117e-06	5.08529846615539e-05	2.64706108706759e-05	2308/8850/2033/1387/2309	5
R-HSA-5357801	Programmed Cell Death	15/125	126/3951	7.22482039368676e-06	5.56526934807144e-05	2.89690133792036e-05	836/1499/1869/7157/10971/5594/5595/5580/5599/6774/148022/207/5062/5747/7027	15
R-HSA-388841	Costimulation by the CD28 family	10/125	56/3951	7.26237071520311e-06	5.56526934807144e-05	2.89690133792036e-05	6714/5170/5295/5290/2534/207/5058/5062/5879/5515	10
R-HSA-9006115	Signaling by NTRK2 (TRKB)	7/125	25/3951	8.02330689611687e-06	6.08434106288863e-05	3.16709482741456e-05	1020/6714/5295/6464/5290/2534/5879	7
R-HSA-6804114	TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest	6/125	17/3951	8.27227389991669e-06	6.20846948364881e-05	3.23170765487793e-05	7157/983/2033/1874/5933/7027	6
R-HSA-186797	Signaling by PDGF	9/125	49/3951	1.67793393546362e-05	0.000124646520920154	6.48825152273794e-05	6772/5155/5156/5159/6714/1398/5295/6774/5290	9
R-HSA-9013695	NOTCH4 Intracellular Domain Regulates Transcription	6/125	19/3951	1.72133676985316e-05	0.000126579107924556	6.58884887982073e-05	4088/8850/2033/9794/4851/1387	6
R-HSA-9006936	Signaling by TGF-beta family members	12/125	89/3951	1.7744850904442e-05	0.000129182514584338	6.72436455326223e-05	4609/142/4088/4089/3065/7048/6667/1874/5933/4087/387/7027	12
R-HSA-190236	Signaling by FGFR	10/125	62/3951	1.86657737769977e-05	0.000134541418907468	7.0033127250851e-05	2253/2261/2264/5594/5595/6714/5295/6464/5290/5515	10
R-HSA-114604	GPVI-mediated activation cascade	7/125	29/3951	2.34391815488416e-05	0.000165667224927735	8.62351084065709e-05	5170/5295/5290/2534/5879/387/10451	7
R-HSA-8939902	Regulation of RUNX2 expression and activity	7/125	29/3951	2.34391815488416e-05	0.000165667224927735	8.62351084065709e-05	2099/2908/6772/55294/2932/10891/2101	7
R-HSA-5621575	CD209 (DC-SIGN) signaling	6/125	20/3951	2.3957634952467e-05	0.000167703444667269	8.72950261425923e-05	2033/1387/5970/2534/5058/5062	6
R-HSA-210744	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	5/125	13/3951	3.07264288316315e-05	0.000211026794239884	0.000109846220252109	8850/2033/9794/4851/1387	5
R-HSA-8941856	RUNX3 regulates NOTCH signaling	5/125	13/3951	3.07264288316315e-05	0.000211026794239884	0.000109846220252109	8850/2033/9794/4851/1387	5
R-HSA-74751	Insulin receptor signalling cascade	9/125	53/3951	3.25205898287285e-05	0.000220272395259604	0.000114658852361853	2253/2261/2264/5594/5595/5170/5295/6464/5290	9
R-HSA-198753	ERK/MAPK targets	6/125	21/3951	3.2677772923128e-05	0.000220272395259604	0.000114658852361853	5594/1432/5595/6197/5515/4208	6
R-HSA-76002	Platelet activation, signaling and aggregation	17/125	178/3951	3.37955856232075e-05	0.000225717305813716	0.000117493103084063	5594/1432/5595/5155/5580/6714/1398/5170/5295/6464/5290/2534/207/5879/5747/387/10451	17
R-HSA-74752	Signaling by Insulin receptor	9/125	54/3951	3.79946539193125e-05	0.000244796454370201	0.00012742441233845	2253/2261/2264/5594/5595/5170/5295/6464/5290	9
R-HSA-1433557	Signaling by SCF-KIT	8/125	42/3951	3.83335107118171e-05	0.000244796454370201	0.00012742441233845	6772/6714/5295/6774/2241/5290/2534/5879	8
R-HSA-5654736	Signaling by FGFR1	8/125	42/3951	3.83335107118171e-05	0.000244796454370201	0.00012742441233845	2253/5594/5595/6714/5295/6464/5290/5515	8
R-HSA-69231	Cyclin D associated events in G1	8/125	42/3951	3.83335107118171e-05	0.000244796454370201	0.00012742441233845	1869/25/6714/1026/1874/5515/5933/7027	8
R-HSA-69236	G1 Phase	8/125	42/3951	3.83335107118171e-05	0.000244796454370201	0.00012742441233845	1869/25/6714/1026/1874/5515/5933/7027	8
R-HSA-1640170	Cell Cycle	25/125	339/3951	3.9758839733971e-05	0.000251690741968094	0.000131013110336197	1869/4149/4609/7341/7157/7329/898/983/1453/2932/4193/10971/2033/3065/25/5594/5595/6714/1026/207/1874/5515/5933/4605/7027	25
R-HSA-9013508	NOTCH3 Intracellular Domain Regulates Transcription	6/125	22/3951	4.37763950912259e-05	0.000274734617469073	0.000143008187230865	6772/8850/2033/9794/4851/1387	6
R-HSA-109582	Hemostasis	27/125	385/3951	4.533491950713e-05	0.00028208394359992	0.000146833747391514	1020/2625/4602/7157/3065/25/5594/1432/5595/5155/5580/6714/1398/5170/5295/6464/5290/2534/207/5879/857/5515/5747/387/10451/3660/2624	27
R-HSA-69202	Cyclin E associated events during G1/S transition 	8/125	43/3951	4.5859286982308e-05	0.000282928482399324	0.00014727335694586	1869/4149/4609/898/1026/207/1874/7027	8
R-HSA-1839117	Signaling by cytosolic FGFR1 fusion mutants	5/125	14/3951	4.65906601763851e-05	0.000285025215196709	0.00014836477367093	6772/5295/6774/5290/1523	5
R-HSA-195258	RHO GTPase Effectors	17/125	185/3951	5.56376986610655e-05	0.000337535371877131	0.000175697995771786	367/1499/1855/10971/25/5594/1432/5595/5580/6714/5170/5058/5062/5879/5515/5747/387	17
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	8/125	45/3951	6.46384822997322e-05	0.000385711599296763	0.000200775268575527	1869/4149/4609/898/1026/207/1874/7027	8
R-HSA-9013694	Signaling by NOTCH4	8/125	45/3951	6.46384822997322e-05	0.000385711599296763	0.000200775268575527	4088/55294/8850/2033/9794/4851/1387/207	8
R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization	5/125	15/3951	6.81236242251772e-05	0.000403203239316496	0.000209880228678338	5170/5295/6464/5290/2534	5
R-HSA-187687	Signalling to ERKs	7/125	34/3951	7.08061789081654e-05	0.000414426168685269	0.000215722123664975	5594/1432/5595/4914/6714/1398/6464	7
R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	12/125	102/3951	7.11583394033772e-05	0.000414426168685269	0.000215722123664975	2308/2625/4609/6772/7157/1026/5295/6774/6095/207/2309/3091	12
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	8/125	46/3951	7.61938700223579e-05	0.000440231249018068	0.000229154496307843	3725/5594/5595/1026/6774/5970/6197/1051	8
R-HSA-1989781	PPARA activates gene expression	9/125	59/3951	7.85415724447406e-05	0.000450222557006072	0.000234355292831385	10891/2033/5468/1387/406/6095/6667/9575/2101	9
R-HSA-69278	Cell Cycle, Mitotic	21/125	270/3951	8.48568336837121e-05	0.000482623241576113	0.0002512208891952	1869/4149/4609/7157/898/983/1453/2932/2033/3065/25/5594/5595/6714/1026/207/1874/5515/5933/4605/7027	21
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	9/125	60/3951	8.99646288752618e-05	0.000504819214609198	0.000262774605638102	10891/2033/5468/1387/406/6095/6667/9575/2101	9
R-HSA-422475	Axon guidance	25/125	356/3951	9.0146288323071e-05	0.000504819214609198	0.000262774605638102	1020/1956/2043/2932/25/27/2064/5594/1432/5595/5979/6714/5599/5295/6464/5290/1385/2534/6197/5058/5062/5879/5747/387/10451	25
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	6/125	25/3951	9.61004126573757e-05	0.000528711584936783	0.000275211351326261	1499/4609/2033/3065/1387/6932	6
R-HSA-1963642	PI3K events in ERBB2 signaling	5/125	16/3951	9.65915395557584e-05	0.000528711584936783	0.000275211351326261	1956/2064/2066/5295/5290	5
R-HSA-9614657	FOXO-mediated transcription of cell death genes	5/125	16/3951	9.65915395557584e-05	0.000528711584936783	0.000275211351326261	2308/2033/1387/6794/2309	5
R-HSA-5689880	Ub-specific processing proteases	11/125	91/3951	0.000112729423755151	0.000612440451445893	0.000318794913997284	367/2625/4609/4088/4089/7157/4193/7189/5728/4087/3091	11
R-HSA-1236394	Signaling by ERBB4	8/125	49/3951	0.000121597268121595	0.000637511377975039	0.000331845136019396	1956/2099/2066/6714/5295/6464/51741/5290	8
R-HSA-383280	Nuclear Receptor transcription pathway	8/125	49/3951	0.000121597268121595	0.000637511377975039	0.000331845136019396	367/2099/8856/2908/5468/6095/3172/2101	8
R-HSA-1839124	FGFR1 mutant receptor activation	6/125	26/3951	0.000121722639476003	0.000637511377975039	0.000331845136019396	2253/6772/5295/6774/5290/1523	6
R-HSA-354192	Integrin alphaIIb beta3 signaling	6/125	26/3951	0.000121722639476003	0.000637511377975039	0.000331845136019396	6714/1398/5170/6464/207/5747	6
R-HSA-9006921	Integrin signaling	6/125	26/3951	0.000121722639476003	0.000637511377975039	0.000331845136019396	6714/1398/5170/6464/207/5747	6
R-HSA-3899300	SUMOylation of transcription cofactors	7/125	37/3951	0.000125208853037037	0.000651086035792591	0.000338911181152882	7341/7329/10891/2033/1387/9063/10155	7
R-HSA-1226099	Signaling by FGFR in disease	8/125	50/3951	0.000140963935295105	0.000727813793580401	0.000378850442002522	2253/6772/2261/2264/5295/6774/5290/1523	8
R-HSA-2424491	DAP12 signaling	6/125	27/3951	0.000152483610990279	0.000770889366673076	0.000401272660500734	5295/6464/5290/2534/5879/10451	6
R-HSA-5654732	Negative regulation of FGFR3 signaling	6/125	27/3951	0.000152483610990279	0.000770889366673076	0.000401272660500734	2253/2261/5594/5595/6714/5515	6
R-HSA-8941326	RUNX2 regulates bone development	6/125	27/3951	0.000152483610990279	0.000770889366673076	0.000401272660500734	367/4089/25/5594/5595/6714	6
R-HSA-5621481	C-type lectin receptors (CLRs)	10/125	80/3951	0.000176334428710326	0.00088532044207667	0.00046083770842626	2033/5580/6714/1387/5170/5970/7189/2534/5058/5062	10
R-HSA-3928664	Ephrin signaling	5/125	18/3951	0.000180046009713722	0.000888116952661267	0.000462293381952077	6714/2534/5058/5062/5879	5
R-HSA-881907	Gastrin-CREB signalling pathway via PKC and MAPK	5/125	18/3951	0.000180046009713722	0.000888116952661267	0.000462293381952077	1956/5594/5595/1385/6197	5
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	8/125	52/3951	0.000187367482608819	0.000888116952661267	0.000462293381952077	25/5594/5595/1398/5058/5879/5747/10451	8
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	8/125	52/3951	0.000187367482608819	0.000888116952661267	0.000462293381952077	4609/55294/8850/2033/3065/9794/4851/1387	8
R-HSA-2644603	Signaling by NOTCH1 in Cancer	8/125	52/3951	0.000187367482608819	0.000888116952661267	0.000462293381952077	4609/55294/8850/2033/3065/9794/4851/1387	8
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	8/125	52/3951	0.000187367482608819	0.000888116952661267	0.000462293381952077	4609/55294/8850/2033/3065/9794/4851/1387	8
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	8/125	52/3951	0.000187367482608819	0.000888116952661267	0.000462293381952077	4609/55294/8850/2033/3065/9794/4851/1387	8
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	8/125	52/3951	0.000187367482608819	0.000888116952661267	0.000462293381952077	4609/55294/8850/2033/3065/9794/4851/1387	8
R-HSA-5654733	Negative regulation of FGFR4 signaling	6/125	28/3951	0.000189090834701231	0.000888116952661267	0.000462293381952077	2253/2264/5594/5595/6714/5515	6
R-HSA-5689896	Ovarian tumor domain proteases	6/125	28/3951	0.000189090834701231	0.000888116952661267	0.000462293381952077	2099/7157/983/7189/5728/387	6
R-HSA-1980143	Signaling by NOTCH1	9/125	66/3951	0.000191889265584605	0.000889779524494217	0.000463158803958818	4609/55294/8850/2033/3065/9794/4851/1387/3091	9
R-HSA-6806834	Signaling by MET	9/125	66/3951	0.000191889265584605	0.000889779524494217	0.000463158803958818	6714/1398/5295/6464/6774/5290/5771/5879/5747	9
R-HSA-5633007	Regulation of TP53 Activity	12/125	114/3951	0.000210568432816187	0.000970214044874582	0.000505027553723033	1020/7157/983/4193/2033/3065/1432/5170/6794/207/5515/6872	12
R-HSA-3232118	SUMOylation of transcription factors	5/125	19/3951	0.000238200524719146	0.001090628817582	0.00056770730816877	7341/7157/7329/4193/9063	5
R-HSA-418885	DCC mediated attractive signaling	4/125	11/3951	0.000265246673841382	0.00119197270713905	0.000620460055769315	6714/2534/5879/5747	4
R-HSA-4755510	SUMOylation of immune response proteins	4/125	11/3951	0.000265246673841382	0.00119197270713905	0.000620460055769315	7341/7329/9641/5970	4
R-HSA-9614399	Regulation of localization of FOXO transcription factors	4/125	11/3951	0.000265246673841382	0.00119197270713905	0.000620460055769315	2308/10971/207/2309	4
R-HSA-114452	Activation of BH3-only proteins	6/125	30/3951	0.000282936262608316	0.001263666252631	0.000657778847523369	1869/7157/10971/5599/207/7027	6
R-HSA-373752	Netrin-1 signaling	7/125	42/3951	0.000287640794113079	0.00126910604917771	0.000660610436240564	1432/6714/5599/2534/5058/5879/5747	7
R-HSA-9012852	Signaling by NOTCH3	7/125	42/3951	0.000287640794113079	0.00126910604917771	0.000660610436240564	1956/6772/8850/2033/9794/4851/1387	7
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	5/125	20/3951	0.000309614821308038	0.00135782885489308	0.000706793504571299	142/4088/4089/3065/4087	5
R-HSA-201681	TCF dependent signaling in response to WNT	12/125	119/3951	0.000316182062711788	0.00137823418880248	0.000717415135871735	1499/4609/1855/2932/2033/3065/1387/207/857/5515/6932/55553	12
R-HSA-5654738	Signaling by FGFR2	8/125	56/3951	0.000318054043569803	0.00137823418880248	0.000717415135871735	2253/5594/5595/6714/5295/6464/5290/5515	8
R-HSA-5625740	RHO GTPases activate PKNs	6/125	31/3951	0.000341850627094534	0.0014639250383813	0.000762019973709178	367/10971/5170/5058/5879/387	6
R-HSA-6804757	Regulation of TP53 Degradation	6/125	31/3951	0.000341850627094534	0.0014639250383813	0.000762019973709178	7157/983/4193/5170/207/5515	6
R-HSA-373755	Semaphorin interactions	8/125	57/3951	0.00036029619013607	0.00153389255215824	0.000798440310550848	1020/2932/2064/2534/5058/5062/5879/387	8
R-HSA-389359	CD28 dependent Vav1 pathway	4/125	12/3951	0.000388170858151883	0.0016334588712981	0.00085026777569016	2534/5058/5062/5879	4
R-HSA-6804116	TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	4/125	12/3951	0.000388170858151883	0.0016334588712981	0.00085026777569016	1869/7157/898/1026	4
R-HSA-445144	Signal transduction by L1	5/125	21/3951	0.000396157648928325	0.00163865209329443	0.000852971014438977	1956/5594/5595/5058/5879	5
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	5/125	21/3951	0.000396157648928325	0.00163865209329443	0.000852971014438977	5594/1432/5595/5580/5879	5
R-HSA-8940973	RUNX2 regulates osteoblast differentiation	5/125	21/3951	0.000396157648928325	0.00163865209329443	0.000852971014438977	367/25/5594/5595/6714	5
R-HSA-8878171	Transcriptional regulation by RUNX1	11/125	105/3951	0.000407317903913074	0.00166733257762373	0.000867900127160994	2099/2625/4602/8850/2033/3065/25/6714/1387/2624/1997	11
R-HSA-2172127	DAP12 interactions	6/125	32/3951	0.000409962268399241	0.00166733257762373	0.000867900127160994	5295/6464/5290/2534/5879/10451	6
R-HSA-6806003	Regulation of TP53 Expression and Degradation	6/125	32/3951	0.000409962268399241	0.00166733257762373	0.000867900127160994	7157/983/4193/5170/207/5515	6
R-HSA-5655302	Signaling by FGFR1 in disease	6/125	33/3951	0.000488235973734617	0.0019746432715489	0.00102786520786235	2253/6772/5295/6774/5290/1523	6
R-HSA-1250196	SHC1 events in ERBB2 signaling	5/125	22/3951	0.000499799194174529	0.00199919677669812	0.00104064609544726	1956/2064/2066/5580/6464	5
R-HSA-389357	CD28 dependent PI3K/Akt signaling	5/125	22/3951	0.000499799194174529	0.00199919677669812	0.00104064609544726	5170/5295/5290/2534/207	5
R-HSA-198323	AKT phosphorylates targets in the cytosol	4/125	13/3951	0.000547035048960882	0.00217618314559302	0.00113277318162737	2932/4193/1026/207	4
R-HSA-1295596	Spry regulation of FGF signaling	4/125	14/3951	0.000747212804474683	0.00289346234924239	0.00150614003141593	5594/5595/6714/5515	4
R-HSA-169893	Prolonged ERK activation events	4/125	14/3951	0.000747212804474683	0.00289346234924239	0.00150614003141593	5594/5595/4914/1398	4
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	4/125	14/3951	0.000747212804474683	0.00289346234924239	0.00150614003141593	7157/898/55294/6774	4
R-HSA-6785631	ERBB2 Regulates Cell Motility	4/125	14/3951	0.000747212804474683	0.00289346234924239	0.00150614003141593	1956/2064/2066/387	4
R-HSA-918233	TRAF3-dependent IRF activation pathway	4/125	14/3951	0.000747212804474683	0.00289346234924239	0.00150614003141593	2033/1387/9641/29110	4
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	7/125	49/3951	0.000762010279232068	0.00293515070519019	0.00152784015886129	10891/2033/5468/1387/5970/1050/1051	7
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA 	6/125	37/3951	0.000923919351708508	0.0035215355394963	0.00183307228776557	1499/2033/1387/29110/148022/5970	6
R-HSA-76009	Platelet Aggregation (Plug Formation)	6/125	37/3951	0.000923919351708508	0.0035215355394963	0.00183307228776557	6714/1398/5170/6464/207/5747	6
R-HSA-5654708	Downstream signaling of activated FGFR3	5/125	25/3951	0.000934374266740154	0.00354283576138975	0.00184415973698715	2253/2261/5295/6464/5290	5
R-HSA-202403	TCR signaling	8/125	66/3951	0.000986637377635392	0.00369257320552866	0.00192210288315546	5170/5295/5290/5970/7189/5058/5062/5728	8
R-HSA-1181150	Signaling by NODAL	4/125	15/3951	0.000994154324565409	0.00369257320552866	0.00192210288315546	4088/4089/4087/2309	4
R-HSA-5637810	Constitutive Signaling by EGFRvIII	4/125	15/3951	0.000994154324565409	0.00369257320552866	0.00192210288315546	1956/5295/6464/5290	4
R-HSA-5637812	Signaling by EGFRvIII in Cancer	4/125	15/3951	0.000994154324565409	0.00369257320552866	0.00192210288315546	1956/5295/6464/5290	4
R-HSA-2682334	EPH-Ephrin signaling	9/125	83/3951	0.00108277630550502	0.00400132563658706	0.00208281843431368	2043/6714/2534/5058/5062/5879/5747/387/10451	9
R-HSA-2404192	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	7/125	52/3951	0.00109696904185488	0.00401303247472538	0.00208891221934809	2253/2261/2264/5170/5295/6464/5290	7
R-HSA-2428924	IGF1R signaling cascade	7/125	52/3951	0.00109696904185488	0.00401303247472538	0.00208891221934809	2253/2261/2264/5170/5295/6464/5290	7
R-HSA-350054	Notch-HLH transcription pathway	5/125	26/3951	0.0011278627494221	0.00406477268108557	0.00211584465759226	8850/3065/9794/4851/1387	5
R-HSA-442742	CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling	5/125	26/3951	0.0011278627494221	0.00406477268108557	0.00211584465759226	5594/5595/5170/1385/6197	5
R-HSA-5654716	Downstream signaling of activated FGFR4	5/125	26/3951	0.0011278627494221	0.00406477268108557	0.00211584465759226	2253/2264/5295/6464/5290	5
R-HSA-113510	E2F mediated regulation of DNA replication	4/125	16/3951	0.00129334191956863	0.00459294106071201	0.00239077325311788	1869/983/5515/7027	4
R-HSA-399954	Sema3A PAK dependent Axon repulsion	4/125	16/3951	0.00129334191956863	0.00459294106071201	0.00239077325311788	2534/5058/5062/5879	4
R-HSA-9008059	Interleukin-37 signaling	4/125	16/3951	0.00129334191956863	0.00459294106071201	0.00239077325311788	4088/6774/29110/5771	4
R-HSA-3928662	EPHB-mediated forward signaling	6/125	40/3951	0.00141155045790169	0.00498839190947783	0.00259661811366689	6714/2534/5058/5879/5747/387	6
R-HSA-6807070	PTEN Regulation	8/125	71/3951	0.0016011743469088	0.00558599167089522	0.00290768797212591	3725/7157/3065/5468/5594/5595/207/5728	8
R-HSA-933541	TRAF6 mediated IRF7 activation	5/125	28/3951	0.00160181134625955	0.00558599167089522	0.00290768797212591	2033/1387/9641/29110/7189	5
R-HSA-375165	NCAM signaling for neurite out-growth	6/125	41/3951	0.00161134375121978	0.00558599167089522	0.00290768797212591	5594/5595/6714/1385/2534/5747	6
R-HSA-8943724	Regulation of PTEN gene transcription	6/125	41/3951	0.00161134375121978	0.00558599167089522	0.00290768797212591	3725/7157/3065/5468/5594/5595	6
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	4/125	17/3951	0.00165024982295005	0.00558782265631458	0.00290864105881037	1956/5295/6464/5290	4
R-HSA-180292	GAB1 signalosome	4/125	17/3951	0.00165024982295005	0.00558782265631458	0.00290864105881037	1956/6714/5295/5290	4
R-HSA-3232142	SUMOylation of ubiquitinylation proteins	4/125	17/3951	0.00165024982295005	0.00558782265631458	0.00290864105881037	7341/7329/4193/9063	4
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	4/125	17/3951	0.00165024982295005	0.00558782265631458	0.00290864105881037	1956/5295/6464/5290	4
R-HSA-9034015	Signaling by NTRK3 (TRKC)	4/125	17/3951	0.00165024982295005	0.00558782265631458	0.00290864105881037	6714/5295/6464/5290	4
R-HSA-438064	Post NMDA receptor activation events	8/125	72/3951	0.00175432910233593	0.00591273882639148	0.00307777035497532	2066/5594/5595/6714/5170/1385/6197/5879	8
R-HSA-556833	Metabolism of lipids	14/125	184/3951	0.00176965457560381	0.00593690567299342	0.00309034997437483	7329/10891/2033/5468/1387/5295/5290/406/6095/6667/857/5728/9575/2101	14
R-HSA-5654710	PI-3K cascade:FGFR3	4/125	18/3951	0.00207030805530328	0.00689694388098889	0.00359008067836322	2253/2261/5295/5290	4
R-HSA-109704	PI3K Cascade	6/125	43/3951	0.00207476745870408	0.00689694388098889	0.00359008067836322	2253/2261/2264/5170/5295/5290	6
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	5/125	30/3951	0.00220796312219552	0.00727329028487936	0.00378598106211187	1499/1855/2932/857/5515	5
R-HSA-5654726	Negative regulation of FGFR1 signaling	5/125	30/3951	0.00220796312219552	0.00727329028487936	0.00378598106211187	2253/5594/5595/6714/5515	5
R-HSA-69242	S Phase	9/125	92/3951	0.00225221237227578	0.00738563336494039	0.00384445924143803	1869/4149/4609/898/2932/1026/207/1874/7027	9
R-HSA-442755	Activation of NMDA receptors and postsynaptic events	8/125	76/3951	0.00248661445211673	0.00811773686610304	0.00422554261393449	2066/5594/5595/6714/5170/1385/6197/5879	8
R-HSA-5654720	PI-3K cascade:FGFR4	4/125	19/3951	0.00255887006345905	0.00819584606259857	0.00426620095797496	2253/2264/5295/5290	4
R-HSA-6804758	Regulation of TP53 Activity through Acetylation	4/125	19/3951	0.00255887006345905	0.00819584606259857	0.00426620095797496	7157/2033/3065/207	4
R-HSA-8862803	Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models	4/125	19/3951	0.00255887006345905	0.00819584606259857	0.00426620095797496	1020/3725/5052/2309	4
R-HSA-8863678	Neurodegenerative Diseases	4/125	19/3951	0.00255887006345905	0.00819584606259857	0.00426620095797496	1020/3725/5052/2309	4
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	5/125	31/3951	0.00256683090971494	0.00819584606259857	0.00426620095797496	25/5594/5595/5879/5747	5
R-HSA-195721	Signaling by WNT	14/125	192/3951	0.00264436553115686	0.00840654195057727	0.00437587493089621	1499/4609/1855/2932/2033/3065/1387/207/5879/857/5515/387/6932/55553	14
R-HSA-1592230	Mitochondrial biogenesis	6/125	46/3951	0.00295036583934444	0.00933854926540328	0.00486101465521281	10891/1432/1387/1385/2101/4208	6
R-HSA-5654727	Negative regulation of FGFR2 signaling	5/125	32/3951	0.0029662510284771	0.009348185059443	0.00486603039531446	2253/5594/5595/6714/5515	5
R-HSA-167044	Signalling to RAS	4/125	20/3951	0.0031211838739968	0.00960231343075908	0.00499831236997291	1432/4914/6714/6464	4
R-HSA-389513	CTLA4 inhibitory signaling	4/125	20/3951	0.0031211838739968	0.00960231343075908	0.00499831236997291	6714/2534/207/5515	4
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	4/125	20/3951	0.0031211838739968	0.00960231343075908	0.00499831236997291	5599/7189/5602/5601	4
R-HSA-912631	Regulation of signaling by CBL	4/125	20/3951	0.0031211838739968	0.00960231343075908	0.00499831236997291	1398/5295/5290/2534	4
R-HSA-1250342	PI3K events in ERBB4 signaling	3/125	10/3951	0.00315240784333986	0.00960231343075908	0.00499831236997291	2066/5295/5290	3
R-HSA-74749	Signal attenuation	3/125	10/3951	0.00315240784333986	0.00960231343075908	0.00499831236997291	5594/5595/6464	3
R-HSA-8853334	Signaling by FGFR3 fusions in cancer	3/125	10/3951	0.00315240784333986	0.00960231343075908	0.00499831236997291	2261/5295/5290	3
R-HSA-9013973	TICAM1-dependent activation of IRF3/IRF7	3/125	10/3951	0.00315240784333986	0.00960231343075908	0.00499831236997291	9641/29110/148022	3
R-HSA-983231	Factors involved in megakaryocyte development and platelet production	9/125	97/3951	0.00324389408289079	0.00983981205143539	0.00512193802561703	1020/2625/4602/7157/3065/25/5879/3660/2624	9
R-HSA-194315	Signaling by Rho GTPases	18/125	285/3951	0.00329602071672098	0.00991548487672997	0.00516132816024116	367/1499/1855/10971/25/5594/1432/5595/5580/6714/5170/5058/5062/5879/5515/5747/387/10451	18
R-HSA-112399	IRS-mediated signalling	6/125	47/3951	0.00329608151122068	0.00991548487672997	0.00516132816024116	2253/2261/2264/5170/5295/5290	6
R-HSA-202424	Downstream TCR signaling	6/125	48/3951	0.00367116134050702	0.0109983763616836	0.00572500793841251	5170/5295/5290/5970/7189/5728	6
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	4/125	21/3951	0.00376236651518938	0.0112254214059749	0.00584319217199387	1387/406/9575/8553	4
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	5/125	34/3951	0.00389686897567585	0.0115792678134368	0.00602738058536329	1499/3065/207/6932/55553	5
R-HSA-193704	p75 NTR receptor-mediated signalling	8/125	82/3951	0.0040121003065747	0.0118732074113268	0.00618038558137309	836/3065/5599/5970/7189/5879/387/10451	8
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	3/125	11/3951	0.0042350932819018	0.0123821201173675	0.00644529098070027	1869/5515/7027	3
R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	3/125	11/3951	0.0042350932819018	0.0123821201173675	0.00644529098070027	2033/9794/1385	3
R-HSA-5655291	Signaling by FGFR4 in disease	3/125	11/3951	0.0042350932819018	0.0123821201173675	0.00644529098070027	2264/5295/5290	3
R-HSA-5655332	Signaling by FGFR3 in disease	4/125	22/3951	0.0044873814754149	0.0130151940800878	0.00677482629964087	2253/2261/5295/5290	4
R-HSA-8853338	Signaling by FGFR3 point mutants in cancer	4/125	22/3951	0.0044873814754149	0.0130151940800878	0.00677482629964087	2253/2261/5295/5290	4
R-HSA-2428928	IRS-related events triggered by IGF1R	6/125	51/3951	0.00498747073360754	0.0144082487859773	0.00749995599038727	2253/2261/2264/5170/5295/5290	6
R-HSA-112409	RAF-independent MAPK1/3 activation	4/125	23/3951	0.00530101897937137	0.0151338894783622	0.0078776752634621	983/5594/5595/1843	4
R-HSA-1643713	Signaling by EGFR in Cancer	4/125	23/3951	0.00530101897937137	0.0151338894783622	0.0078776752634621	1956/5295/6464/5290	4
R-HSA-397795	G-protein beta:gamma signalling	4/125	23/3951	0.00530101897937137	0.0151338894783622	0.0078776752634621	5170/207/5058/387	4
R-HSA-111461	Cytochrome c-mediated apoptotic response	3/125	12/3951	0.0055174007564851	0.0154487221181583	0.00804155575843982	836/5594/5595	3
R-HSA-1502540	Signaling by Activin	3/125	12/3951	0.0055174007564851	0.0154487221181583	0.00804155575843982	4088/4089/4087	3
R-HSA-170968	Frs2-mediated activation	3/125	12/3951	0.0055174007564851	0.0154487221181583	0.00804155575843982	5594/5595/4914	3
R-HSA-202670	ERKs are inactivated	3/125	12/3951	0.0055174007564851	0.0154487221181583	0.00804155575843982	5594/5595/5515	3
R-HSA-8866910	TFAP2 (AP-2) family regulates transcription of growth factors and their receptors	3/125	12/3951	0.0055174007564851	0.0154487221181583	0.00804155575843982	1956/2099/2064	3
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	5/125	37/3951	0.00566002301179951	0.0157270868419467	0.00818645353253444	10891/1387/1385/2101/4208	5
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	5/125	37/3951	0.00566002301179951	0.0157270868419467	0.00818645353253444	7341/7157/7329/25/5599	5
R-HSA-982772	Growth hormone receptor signaling	4/125	24/3951	0.00620787887606092	0.0171837863945717	0.00894471240897311	6772/5594/5595/6774	4
R-HSA-5617472	Activation of anterior HOX genes in hindbrain development during early embryogenesis	5/125	38/3951	0.00635561371519465	0.0173943112205327	0.00905429733862317	3725/2033/1387/9063/10664	5
R-HSA-5619507	Activation of HOX genes during differentiation	5/125	38/3951	0.00635561371519465	0.0173943112205327	0.00905429733862317	3725/2033/1387/9063/10664	5
R-HSA-5693606	DNA Double Strand Break Response	5/125	38/3951	0.00635561371519465	0.0173943112205327	0.00905429733862317	7341/7157/7329/25/5599	5
R-HSA-3371568	Attenuation phase	3/125	13/3951	0.00700851046874237	0.0188970208194239	0.00983650592104192	2033/1387/2288	3
R-HSA-428540	Activation of RAC1	3/125	13/3951	0.00700851046874237	0.0188970208194239	0.00983650592104192	5058/5062/5879	3
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	3/125	13/3951	0.00700851046874237	0.0188970208194239	0.00983650592104192	4089/6774/4087	3
R-HSA-8847993	ERBB2 Activates PTK6 Signaling	3/125	13/3951	0.00700851046874237	0.0188970208194239	0.00983650592104192	1956/2064/2066	3
R-HSA-8853659	RET signaling	5/125	39/3951	0.00710919732370294	0.019097769932309	0.00994100227824067	5979/6714/5295/6464/5290	5
R-HSA-8863795	Downregulation of ERBB2 signaling	4/125	25/3951	0.00721235594450296	0.0193036585573462	0.0100481739164902	1956/2064/2066/207	4
R-HSA-3371556	Cellular response to heat stress	6/125	55/3951	0.0072443939326594	0.0193183838204251	0.010055838888596	2932/2033/5594/5595/1387/2288	6
R-HSA-195253	Degradation of beta-catenin by the destruction complex	5/125	40/3951	0.00792314687596026	0.0210512807507265	0.0109578673659074	1499/2932/3065/5515/6932	5
R-HSA-3928663	EPHA-mediated growth cone collapse	4/125	26/3951	0.00831862743451766	0.0217059525889923	0.01129864507235	2043/6714/2534/387	4
R-HSA-5250913	Positive epigenetic regulation of rRNA expression	4/125	26/3951	0.00831862743451766	0.0217059525889923	0.01129864507235	2932/8850/2033/3065	4
R-HSA-525793	Myogenesis	4/125	26/3951	0.00831862743451766	0.0217059525889923	0.01129864507235	1499/25/1432/4208	4
R-HSA-69563	p53-Dependent G1 DNA Damage Response	4/125	26/3951	0.00831862743451766	0.0217059525889923	0.01129864507235	7157/898/4193/1026	4
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	4/125	26/3951	0.00831862743451766	0.0217059525889923	0.01129864507235	7157/898/4193/1026	4
R-HSA-1368082	RORA activates gene expression	3/125	14/3951	0.00871613710445173	0.0218053189417212	0.0113503684485535	2033/1387/6095	3
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	3/125	14/3951	0.00871613710445173	0.0218053189417212	0.0113503684485535	6714/1398/5747	3
R-HSA-399956	CRMPs in Sema3A signaling	3/125	14/3951	0.00871613710445173	0.0218053189417212	0.0113503684485535	1020/2932/2534	3
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	3/125	14/3951	0.00871613710445173	0.0218053189417212	0.0113503684485535	1499/2932/5515	3
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	3/125	14/3951	0.00871613710445173	0.0218053189417212	0.0113503684485535	1499/2932/5515	3
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	3/125	14/3951	0.00871613710445173	0.0218053189417212	0.0113503684485535	1499/2932/5515	3
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	3/125	14/3951	0.00871613710445173	0.0218053189417212	0.0113503684485535	1499/2932/5515	3
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	3/125	14/3951	0.00871613710445173	0.0218053189417212	0.0113503684485535	1499/2932/5515	3
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	3/125	14/3951	0.00871613710445173	0.0218053189417212	0.0113503684485535	1499/2932/5515	3
R-HSA-877312	Regulation of IFNG signaling	3/125	14/3951	0.00871613710445173	0.0218053189417212	0.0113503684485535	6772/7341/5771	3
R-HSA-8849471	PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases	3/125	14/3951	0.00871613710445173	0.0218053189417212	0.0113503684485535	1398/5879/387	3
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	3/125	14/3951	0.00871613710445173	0.0218053189417212	0.0113503684485535	9641/29110/148022	3
R-HSA-4551638	SUMOylation of chromatin organization proteins	4/125	27/3951	0.00953064267072275	0.0237613283023499	0.0123685341076431	7341/7329/3065/9063	4
R-HSA-451927	Interleukin-2 family signaling	5/125	42/3951	0.00974138421074674	0.0242038488239714	0.0125988802438255	6772/5295/6464/6774/5290	5
R-HSA-210745	Regulation of gene expression in beta cells	3/125	15/3951	0.0106466327994233	0.0262737243321362	0.0136763168877516	2308/207/3172	3
R-HSA-6804760	Regulation of TP53 Activity through Methylation	3/125	15/3951	0.0106466327994233	0.0262737243321362	0.0136763168877516	7157/4193/2033	3
R-HSA-75153	Apoptotic execution phase	5/125	43/3951	0.0107501495728576	0.0263344646610701	0.0137079341786947	836/1499/5580/5062/5747	5
R-HSA-8986944	Transcriptional Regulation by MECP2	5/125	43/3951	0.0107501495728576	0.0263344646610701	0.0137079341786947	3065/5468/1385/5728/4208	5
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	4/125	28/3951	0.0108521145581333	0.0263344646610701	0.0137079341786947	4088/4089/7048/4087	4
R-HSA-5654687	Downstream signaling of activated FGFR1	4/125	28/3951	0.0108521145581333	0.0263344646610701	0.0137079341786947	2253/5295/6464/5290	4
R-HSA-69615	G1/S DNA Damage Checkpoints	4/125	28/3951	0.0108521145581333	0.0263344646610701	0.0137079341786947	7157/898/4193/1026	4
R-HSA-8939236	RUNX1 regulates transcription of genes involved in differentiation of HSCs	4/125	29/3951	0.0122865128374723	0.0297162170952819	0.0154682448731947	2625/4602/25/2624	4
R-HSA-111471	Apoptotic factor-mediated response	3/125	16/3951	0.0128050845409282	0.0305642673632648	0.015909682259652	836/5594/5595	3
R-HSA-196299	Beta-catenin phosphorylation cascade	3/125	16/3951	0.0128050845409282	0.0305642673632648	0.015909682259652	1499/2932/5515	3
R-HSA-1963640	GRB2 events in ERBB2 signaling	3/125	16/3951	0.0128050845409282	0.0305642673632648	0.015909682259652	1956/2064/2066	3
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	3/125	16/3951	0.0128050845409282	0.0305642673632648	0.015909682259652	5170/207/387	3
R-HSA-376176	Signaling by ROBO receptors	7/125	81/3951	0.0133825464083842	0.0318382149846526	0.0165728128896399	25/27/6714/5058/5062/5879/387	7
R-HSA-5654696	Downstream signaling of activated FGFR2	4/125	30/3951	0.0138370589475149	0.0328123091654425	0.0170798601786572	2253/5295/6464/5290	4
R-HSA-177929	Signaling by EGFR	5/125	46/3951	0.0142005299949836	0.0333483414075744	0.0173588821670428	1956/6714/5295/6464/5290	5
R-HSA-512988	Interleukin-3, Interleukin-5 and GM-CSF signaling	5/125	46/3951	0.0142005299949836	0.0333483414075744	0.0173588821670428	1398/5295/6464/5290/2534	5
R-HSA-5628897	TP53 Regulates Metabolic Genes	5/125	46/3951	0.0142005299949836	0.0333483414075744	0.0173588821670428	7157/10971/5052/207/5728	5
R-HSA-6804756	Regulation of TP53 Activity through Phosphorylation	6/125	64/3951	0.0148807154539528	0.0348333146317608	0.0181318583970993	1020/7157/4193/1432/6794/6872	6
R-HSA-5250924	B-WICH complex positively regulates rRNA expression	3/125	17/3951	0.0151954062662093	0.0354559479544883	0.0184559590277845	2932/8850/2033	3
R-HSA-1251985	Nuclear signaling by ERBB4	4/125	31/3951	0.0155067223605223	0.0360667536053043	0.0187739029755777	2099/2066/6714/51741	4
R-HSA-112314	Neurotransmitter receptors and postsynaptic signal transmission	9/125	124/3951	0.0157526342145117	0.0365220309177213	0.0190108894308555	4193/2066/5594/5595/6714/5170/1385/6197/5879	9
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	5/125	48/3951	0.0168739713313862	0.0389976226325371	0.0202995143836225	2043/6714/2534/5879/10451	5
R-HSA-453274	Mitotic G2-G2/M phases	8/125	105/3951	0.0171532011022012	0.0395175012734254	0.0205701279040387	1869/7157/983/1453/2033/1026/5515/4605	8
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	3/125	18/3951	0.0178204259083905	0.0405414689415883	0.0211031359441466	2534/5062/5879	3
R-HSA-210993	Tie2 Signaling	3/125	18/3951	0.0178204259083905	0.0405414689415883	0.0211031359441466	5295/6464/5290	3
R-HSA-5654704	SHC-mediated cascade:FGFR3	3/125	18/3951	0.0178204259083905	0.0405414689415883	0.0211031359441466	2253/2261/6464	3
R-HSA-8941858	Regulation of RUNX3 expression and activity	3/125	18/3951	0.0178204259083905	0.0405414689415883	0.0211031359441466	4193/2033/6714	3
R-HSA-168928	DDX58/IFIH1-mediated induction of interferon-alpha/beta	6/125	67/3951	0.0183478782214571	0.0416113873682891	0.0216600628290689	2033/1387/9641/29110/5970/7189	6
R-HSA-2029485	Role of phospholipids in phagocytosis	3/125	19/3951	0.0206819676293151	0.0464705939325352	0.0241894358237604	5580/5295/5290	3
R-HSA-373753	Nephrin family interactions	3/125	19/3951	0.0206819676293151	0.0464705939325352	0.0241894358237604	5295/5290/2534	3
R-HSA-5654719	SHC-mediated cascade:FGFR4	3/125	19/3951	0.0206819676293151	0.0464705939325352	0.0241894358237604	2253/2264/6464	3
